Acasă › Cancer pulmonar cu celule non-pătrate › California › Concord
Studii clinice pentru Cancer pulmonar cu celule non-pătrate în Concord, CA
14 studii pentru Cancer pulmonar cu celule non-pătrate caută participanți în și în jurul orașului Concord (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
În curs de recrutareFaza 3
- Kaiser Permanente-Walnut Creek, Walnut Creek · La 5 mi distanță
- John Muir Medical Center-Walnut Creek, Walnut Creek · La 5 mi distanță
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
În curs de recrutareFaza 3
- Kaiser Permanente-Walnut Creek, Walnut Creek · La 5 mi distanță
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
În curs de recrutareFaza 3
- Local Institution - 0208, Pleasant Hill · La 3 mi distanță
- BASS Cancer Center, Walnut Creek · La 5 mi distanță
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
În curs de recrutareFaza 3
- John Muir Health Clinical Research Center, Concord
- John Muir Health Cancer Center, Walnut Creek · La 5 mi distanță
- John Muir Health Clinical Research Center, Walnut Creek · La 5 mi distanță
- și încă 1
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
În curs de recrutareFaza 2
- Kaiser Permanente Walnut Creek Medical Center, Walnut Creek · La 5 mi distanță
- John Muir Health Clinical Research Center, Walnut Creek · La 5 mi distanță
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
În curs de recrutareFaza 3
- BASS Cancer Center, Walnut Creek · La 5 mi distanță
Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer
În curs de recrutareStudiu observațional
- John Muir Health, Walnut Creek · La 5 mi distanță
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
În curs de recrutareFaza 2/3
- John Muir Clinical Research Center, Concord
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
În curs de recrutareFaza 3
- Research Site, Walnut Creek · La 5 mi distanță
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
În curs de recrutareFaza 3
- BASS Cancer Center, Walnut Creek · La 5 mi distanță
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
În curs de recrutareFaza 3
- Research Site, Walnut Creek · La 5 mi distanță
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
În curs de recrutareFaza 2
- Kaiser Permanente-Walnut Creek, Walnut Creek · La 5 mi distanță
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
În curs de recrutareFaza 2/3
- Kaiser Permanente-Walnut Creek, Walnut Creek · La 5 mi distanță
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
În curs de recrutareStudiu observațional
- Kaiser Permanente-Walnut Creek, Walnut Creek · La 5 mi distanță
- Contra Costa Regional Medical Center, Martinez · La 6 mi distanță
- Contra Costa Regional Medical Center, Martinez · La 6 mi distanță
Studii pentru Cancer pulmonar cu celule non-pătrate în alte orașe
- Houston, TX145 studii
- New York City, NY121 studii
- Arlington, VA104 studii
- Nashville, TN97 studii
- Boston, MA90 studii
- Los Angeles, CA87 studii
- St. Louis, MO73 studii
- Chicago, IL61 studii
- Baltimore, MD60 studii
- San Antonio, TX59 studii
- Columbus, OH57 studii
- Washington, DC55 studii
Alte studii în Concord
- Obezitate18 studii
- Supraponderalitate16 studii
- Tulburare depresivă majoră12 studii
- Diabet de tip 210 studii
- Cancer de sân9 studii
- Cancer pulmonar9 studii
- Migrenă8 studii
- Cancer (toate tipurile)7 studii
- Depresie6 studii
- Cancer de prostată6 studii
- Diabet5 studii
- Boala Alzheimer5 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.